Nyxoah (NYXH) Research & Development (2021 - 2026)
Nyxoah (NYXH) posted Research & Development of -$11.1 million for Q2 2026, down 7.62% on a QoQ basis from -$10.3 million in Q1 2026, and up 2.58% year-over-year from -$10.8 million in Q2 2025.
Powered by 
Analysis
Nyxoah (NYXH) Research & Development (2021 - 2026) Analysis & Trends
Nyxoah has reported Research & Development for 6 years, with the latest figure at -$11.1 million in Q2 2026.
- On a quarterly basis, Research & Development rose 2.58% year-over-year to -$11.1 million in Q2 2026; TTM through Jun 2026 was -$49.1 million, a 16.78% decrease from a year earlier, with the FY2025 full-year figure at -$48.4 million, down 30.23% from the prior year.
- Research & Development was -$11.1 million for Q2 2026 at Nyxoah, down from -$10.3 million in the prior quarter.
- The five-year high for Research & Development was -$3.7 million in Q2 2022, with the low at -$15.1 million in Q3 2025.
- Average Research & Development over 5 years is -$8.5 million, with a median of -$8.0 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Research & Development plunged 228.22% in 2022, then increased 2.58% in 2026.
- Over 5 years, Research & Development stood at -$4.7 million in 2022, then tumbled by 68.76% to -$7.9 million in 2023, then plunged by 59.43% to -$12.6 million in 2024, then decreased by 0.71% to -$12.6 million in 2025, then increased by 12.29% to -$11.1 million in 2026.
- The last three Research & Development figures came in at -$11.1 million (Q2 2026), -$10.3 million (Q1 2026), and -$12.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.18 Bn | 173.23 Bn | 7.27 Bn | 892.00 Mn |
| 2 | Intuitive Surgical | 142.14 Bn | 137.06 Bn | 1.96 Bn | 370.60 Mn |
| 3 | Medtronic | 117.43 Bn | 109.23 Bn | 6.34 Bn | 771.00 Mn |
| 4 | Stryker | 105.15 Bn | 101.68 Bn | 4.50 Bn | 434.00 Mn |
| 5 | Boston Scientific | 63.37 Bn | 63.08 Bn | 3.85 Bn | 554.00 Mn |
| 6 | Edwards Lifesciences | 50.93 Bn | 46.79 Bn | 1.35 Bn | 278.90 Mn |
| 7 | Dexcom | 33.65 Bn | 31.71 Bn | 830.00 Mn | 153.00 Mn |
| 8 | Resmed | 32.27 Bn | 30.80 Bn | 861.22 Mn | 105.73 Mn |
| 9 | Alcon | 31.62 Bn | 30.17 Bn | 1.68 Bn | -663.00 Mn |
| 10 | Nyxoah | 63.68 Mn | -49.98 Mn | 5.33 Mn | -11.09 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -11.09 Mn |
| Mar 31, 2026 | -10.31 Mn |
| Dec 31, 2025 | -12.65 Mn |
| Sep 30, 2025 | -15.09 Mn |
| Jun 30, 2025 | -11.39 Mn |
| Mar 31, 2025 | -9.46 Mn |
| Dec 31, 2024 | -12.56 Mn |
| Sep 30, 2024 | -8.68 Mn |
| Jun 30, 2024 | -8.05 Mn |
| Mar 31, 2024 | -7.82 Mn |
| Dec 31, 2023 | -7.88 Mn |
| Sep 30, 2023 | -7.15 Mn |
| Jun 30, 2023 | -7.19 Mn |
| Mar 31, 2023 | -6.61 Mn |
| Dec 31, 2022 | -4.67 Mn |
| Sep 30, 2022 | -4.26 Mn |
| Jun 30, 2022 | -3.70 Mn |
| Mar 31, 2022 | -4.03 Mn |
| Dec 31, 2021 | -3.82 Mn |
| Sep 30, 2021 | -4.15 Mn |
API Access
Nyxoah Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=NYXH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "NYXH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=NYXH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();